patients reached globally*
2025 Impact Report - Bristol Myers Squibb
“
We’re building a stronger, more resilient company that delivers enduring value for our people, patients, and shareholders. 
Christopher S. Boerner, Ph.D.
”
ENVIRONMENTAL, SOCIAL AND GOVERNANCE
Our annual impact report describes our commitment to building a better future and provides our performance across environmental sustainability, social impact and ethical governance.
Recent sustainability & social impact highlights
Low- and middle-income countries (LMICs)
have potential direct import (DI)
access for 13 BMS medicines
new product fillings in
low-and middle-income countries (LMICs)
grants provided to organizations supporting patients through projects and programs that address health equity
assets in early-stage
clinical development
Established goal to reduce freshwater
withdrawal by 20% by 2033
* Inclusive of current commercially promoted products and not established brands.